Publications by authors named "Yuta Ibe"

Claim this Profile
D
Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patients.
Toshiaki Komatsu, Atsushi Tomizawa, Masaru Samura, Ayako Suzuki, Tomoyuki Ishigo, Yuta Ibe

J Infect Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of discrepancy in estimated renal function on vancomycin area under the blood concentration-time curve: a retrospective cohort study comparing serum creatinine and serum cystatin C.
Yuta Ibe, Tomoyuki Ishigo, Tomohiro Aigami, Satoshi Fujii, Masahide Fukudo

Int J Clin Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study.
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, Satoshi Fujii, Masahide Fukudo

J Pharm Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial cumulative area under the blood concentration-time curve of vancomycin is associated with the incidence of acute kidney injury.
Yuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, Masahide Fukudo

J Chemother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a flowchart related to achieving the target area under the concentration-time curve for vancomycin: A retrospective multicenter study.
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, Satoshi Fujii, Masahide Fukudo

J Infect Chemother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortening the interval between the first and the second dose of vancomycin facilitates rapid achievement of the target AUC without increasing the risk of acute kidney injury, provided the AUC on the second day is appropriately controlled: a multicenter retrospective study.
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, Satoshi Fujii, Masahide Fukudo

J Pharm Health Care Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Mitsuboshi, "Enhancing result reliability by addressing potential confounding factors".
Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, Hiroaki Tanaka, Yuta Ibe

Microbiol Spectr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced age.
Keisuke Takada, Masaru Samura, Yuki Igarashi, Ayako Suzuki, Tomoyuki Ishigo, Yuta Ibe

J Pharm Health Care Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation.
Ayako Suzuki, Masaru Samura, Tomoyuki Ishigo, Satoshi Fujii, Yuta Ibe

Pharm Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study.
Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, Hiroaki Tanaka, Yuta Ibe

Microbiol Spectr· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective study.
Tomoyuki Ishigo, Satoshi Fujii, Yuta Ibe, Tomohiro Aigami, Keita Nakano

J Infect Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
Tomoyuki Ishigo, Yuta Ibe, Satoshi Fujii, Satoshi Kazuma, Tomohiro Aigami

J Infect Chemother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report.
Yuta Ibe, Ryuichiro Kakizaki, Hirotoshi Inamura, Tomoyuki Ishigo, Yoshihiro Fujiya

J Pharm Health Care Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration-Time Curve in ICU Patients.
Yuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, Satoshi Takahashi, Masahide Fukudo

Antibiotics (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical condition.
Yuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, Yoshihiro Fujiya, Koji Kuronuma

J Infect Chemother· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients.
Satoshi Fujii, Yuta Ibe, Tomoyuki Ishigo, Hirotoshi Inamura, Yusuke Kunimoto

J Infect Chemother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Association Suvorexant and Ramelteon Use with the Risk of Falling: A Retrospective Case-control Study].
Tomoyuki Ishigo, Ryo Takada, Fuki Kondo, Yuta Ibe, Keita Nakano

Yakugaku Zasshi· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis